Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$224.58 - $256.19 $111,391 - $127,070
496 Added 5.5%
9,522 $2.38 Million
Q4 2023

Feb 06, 2024

SELL
$185.1 - $233.13 $53,123 - $66,908
-287 Reduced 3.08%
9,026 $2.09 Million
Q3 2023

Nov 03, 2023

BUY
$233.08 - $265.59 $258,252 - $294,273
1,108 Added 13.5%
9,313 $2.31 Million
Q2 2023

Aug 04, 2023

BUY
$224.99 - $256.14 $67,497 - $76,842
300 Added 3.8%
8,205 $1.97 Million
Q1 2023

May 01, 2023

BUY
$239.75 - $277.0 $167,585 - $193,623
699 Added 9.7%
7,905 $1.99 Million
Q4 2022

Feb 07, 2023

BUY
$241.42 - $282.29 $491,289 - $574,460
2,035 Added 39.35%
7,206 $1.91 Million
Q3 2022

Nov 03, 2022

BUY
$247.06 - $1507.4 $180,353 - $1.1 Million
730 Added 16.44%
5,171 $1.34 Million
Q2 2022

Aug 02, 2022

BUY
$237.11 - $299.66 $86,308 - $109,076
364 Added 8.93%
4,441 $1.13 Million
Q1 2022

May 09, 2022

BUY
$257.27 - $315.76 $174,686 - $214,401
679 Added 19.98%
4,077 $1.2 Million
Q4 2021

Jan 26, 2022

BUY
$292.08 - $329.01 $66,594 - $75,014
228 Added 7.19%
3,398 $1.12 Million
Q3 2021

Nov 05, 2021

SELL
$272.21 - $332.43 $16,060 - $19,613
-59 Reduced 1.83%
3,170 $965,000
Q2 2021

Aug 13, 2021

BUY
$225.08 - $271.69 $2,475 - $2,988
11 Added 0.34%
3,229 $867,000
Q1 2021

May 10, 2021

SELL
$212.38 - $245.9 $180,098 - $208,523
-848 Reduced 20.86%
3,218 $724,000
Q4 2020

Feb 05, 2021

BUY
$212.5 - $245.46 $11,262 - $13,009
53 Added 1.32%
4,066 $903,000
Q3 2020

Nov 09, 2020

SELL
$177.16 - $215.33 $4,783 - $5,813
-27 Reduced 0.67%
4,013 $864,000
Q2 2020

Jul 31, 2020

BUY
$128.7 - $176.83 $59,330 - $81,518
461 Added 12.88%
4,040 $714,000
Q1 2020

Apr 24, 2020

BUY
$121.39 - $169.05 $51,712 - $72,015
426 Added 13.51%
3,579 $495,000
Q4 2019

Feb 07, 2020

BUY
$133.47 - $153.48 $16,950 - $19,491
127 Added 4.2%
3,153 $484,000
Q3 2019

Nov 06, 2019

BUY
$135.4 - $146.47 $48,744 - $52,729
360 Added 13.5%
3,026 $437,000
Q2 2019

Aug 06, 2019

BUY
$124.88 - $143.73 $10,115 - $11,642
81 Added 3.13%
2,666 $381,000
Q1 2019

May 15, 2019

BUY
$97.62 - $132.29 $33,581 - $45,507
344 Added 15.35%
2,585 $341,000
Q4 2018

Feb 08, 2019

BUY
$94.85 - $109.54 $16,219 - $18,731
171 Added 8.26%
2,241 $231,000
Q3 2018

Nov 06, 2018

BUY
$98.13 - $108.9 $203,129 - $225,423
2,070 New
2,070 $225,000
Q1 2018

May 09, 2018

SELL
$92.16 - $103.8 $253,992 - $286,072
-2,756 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$85.26 - $94.62 $234,976 - $260,772
2,756
2,756 $256,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.